In addition to analgesia, KOR agonists showed potential for the treatment of pruritis, multiple sclerosis, Alzheimer’s disease, immune mediated diseases such as osteoarthritis, atopic dermatitis, food allergy, gastrointestinal (GIT) diseases, cancer, and hypoxia and ischemia [9]. The gene discussed is OPRK1; the disease is cancer.